137 related articles for article (PubMed ID: 8689945)
1. Pharmacokinetics of sodium mercaptoundecahydrododecaborate after intravenous injection in rats.
Mehta SC; Boudinot FD; Lu DR
Drug Metab Dispos; 1995 Dec; 23(12):1368-71. PubMed ID: 8689945
[TBL] [Abstract][Full Text] [Related]
2. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
3. Boron neutron capture therapy: long-term effects on the skin and spinal cord of the rat.
Morris GM; Constantine G; Ross G; Yeung TK; Hopewell JW
Radiat Res; 1993 Sep; 135(3):380-6. PubMed ID: 8378531
[TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
[TBL] [Abstract][Full Text] [Related]
5. Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy.
Mehta SC; Lai JC; Lu DR
J Microencapsul; 1996; 13(3):269-79. PubMed ID: 8860683
[TBL] [Abstract][Full Text] [Related]
6. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
7. Intra-arterial administration of sodium borocaptate (BSH)/lipiodol emulsion delivers B-10 to liver tumors highly selectively for boron neutron capture therapy: experimental studies in the rat liver model.
Suzuki M; Masunaga S; Kinashi Y; Nagata K; Sakurai Y; Nakamatsu K; Nishimura Y; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):260-6. PubMed ID: 15093923
[TBL] [Abstract][Full Text] [Related]
8. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent disposition kinetics and tissue accumulation of boron after intravenous injections of sodium mercaptoundecahydrododecaborate in rabbits.
Buchar E; Bednárová S; Grüner B; Walder P; Strouf O; Janků I
Cancer Chemother Pharmacol; 1992; 29(6):450-4. PubMed ID: 1568287
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution of 10B in a rat liver tumor model following intra-arterial administration of sodium borocaptate (BSH)/degradable starch microspheres (DSM) emulsion.
Suzuki M; Nagata K; Masunaga S; Kinashi Y; Sakurai Y; Maruhashi A; Ono K
Appl Radiat Isot; 2004 Nov; 61(5):933-7. PubMed ID: 15308171
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer.
Ichikawa H; Taniguchi E; Fujimoto T; Fukumori Y
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S111-4. PubMed ID: 19376721
[TBL] [Abstract][Full Text] [Related]
12. Subcellular biodistribution of sodium borocaptate (BSH: Na2B12H11SH) in a rat glioma model in boron neutron capture therapy.
Kageji T; Nagahiro S; Otersen B; Gabel D; Nakaichi M; Nakagawa Y
J Neurooncol; 2002 Sep; 59(2):135-42. PubMed ID: 12241106
[TBL] [Abstract][Full Text] [Related]
13. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):663-72. PubMed ID: 9112465
[TBL] [Abstract][Full Text] [Related]
14. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
15. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
16. Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma.
Kageji T; Nagahiro S; Kitamura K; Nakagawa Y; Hatanaka H; Haritz D; Grochulla F; Haselsberger K; Gabel D
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):120-30. PubMed ID: 11516861
[TBL] [Abstract][Full Text] [Related]
17. The diuretic effect of borocaptate sodium in rats and in patients with brain tumors.
Horn V; Slánsky J; Buchar E; Janku I; Sourek K; Tovarys F
Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):559-66. PubMed ID: 9442480
[TBL] [Abstract][Full Text] [Related]
18. Boron neutron capture therapy of brain tumors: investigation of urinary metabolites and oxidation products of sodium borocaptate by electrospray ionization mass spectrometry.
Gibson CR; Staubus AE; Barth RF; Yang W; Kleinholz NM; Jones RB; Green-Church K; Tjarks W; Soloway AH
Drug Metab Dispos; 2001 Dec; 29(12):1588-98. PubMed ID: 11717178
[TBL] [Abstract][Full Text] [Related]
19. Disposition of TF-PEG-Liposome-BSH in tumor-bearing mice.
Ito Y; Kimura Y; Shimahara T; Ariyoshi Y; Shimahara M; Miyatake S; Kawabata S; Kasaoka S; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S109-10. PubMed ID: 19395268
[TBL] [Abstract][Full Text] [Related]
20. The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy.
Masunaga S; Kasaoka S; Maruyama K; Nigg D; Sakurai Y; Nagata K; Suzuki M; Kinashi Y; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1515-22. PubMed ID: 17126210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
